By proceeding, you agree to our Terms of Use and Privacy Policy.
The 2nd NSCLC Drug Development Summit returns for its second year to unite biopharma and academic leaders during an exciting era of personalized medicine.
Address mechanisms of drug resistance, spearhead progress in molecular subtyping and define practice-changing drug sequencing for the largest solid tumor indication.
Improve your drug development rationale across all lines of NSCLC and address challenges when moving therapies forward!
Optimize the clinical application of immune checkpoint inhibitors and revolutionize your trial design, patient recruitment and patient voice.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Natera is a global leader in providing DNA testing across multiple clinical areas including women's health, organ health, and oncology.
A leading data-driven diagnostic solutions company helping answer critical clinical questions faced by physicians, researchers, and biopharmaceutical companies, with a primary focus in lung disease.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.